Caris Life Sciences Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Caris Life Sciences Inc had 821.15M in cash and cash equivalents.

Caris Life Sciences Inc reported 548.36M in total liabilities as of the latest reported quarter, including 127.14M in current liabilities and 421.21M in non-current liabilities.

As of the latest reported quarter, Caris Life Sciences Inc's total assets were 1.13B, consisting of 997.80M in current assets and 127.86M in non-current assets.

Caris Life Sciences Inc reported 577.31M in total shareholders' equity as of the latest reported quarter.